Literature DB >> 11782875

Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women.

László B Tankó1, Lusine Movsesyan, Ulrik Mouritzen, Claus Christiansen, Ole L Svendsen.   

Abstract

Studies indicate that deficient skeletal muscle mass or sarcopenia is a major cause of disability and morbidity among the elderly. In part, due to the lack of generally applicable normal values, there is still insufficient epidemiologic data available on the frequency and severity of sarcopenia in health and under various disease-related conditions. The objectives of the present study were to (1) characterize the age- and menopause-related variations in appendicular lean tissue mass (LTM(A)), (2) provide young-normal means and estimate the age-specific prevalence of sarcopenia among healthy women. A total of 754 healthy women were included in the study of cross-sectional design. LTM(A) was estimated by dual-energy x-ray absorptiometry (DEXA). Physical characteristics and menopausal status were also registered. LTM(A) as well as height showed significant negative correlation with age with Pearson's r values of -0.43 and -0.06, respectively (P <.05). Trend of finding lower mean values with advancing age remained even when LTM(A) was adjusted for height(2) (ht(2)). Menopause did not seem to have any influence on LTM(A). Young-normal means were obtained from 216 premenopausal women aged 18 to 39 years. Prevalence rates of sarcopenia in healthy women were determined with reference to a cut-off line corresponding to LTM(A) or LTM(A)/ht(2) less than young-normal mean 2 SD and were found to be 40.2% and 12.3%, respectively, among the healthy elderly (>70 years of age). Results of the present study provide further evidence that sarcopenia exists even among otherwise healthy women with increasing age-specific prevalence. Further studies are needed (1) to estimate the prevalence of sarcopenia under various health and disease-related conditions with reference to the hereby given cut-off values and (2) to find therapeutic strategies with beneficial effects in conserving skeletal muscle mass. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2002        PMID: 11782875     DOI: 10.1053/meta.2002.28960

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  24 in total

Review 1.  Sarcopenia: diagnosis and treatment.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

Review 2.  Preserving Healthy Muscle during Weight Loss.

Authors:  Edda Cava; Nai Chien Yeat; Bettina Mittendorfer
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 3.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

4.  Sarcopenia: designing phase IIB trials.

Authors:  Wm C Chumlea; M Cesari; W J Evans; L Ferrucci; R A Fielding; M Pahor; S Studenski; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

5.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

Authors:  Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni
Journal:  J Am Med Dir Assoc       Date:  2011-03-04       Impact factor: 4.669

6.  Ethnicity-related skeletal muscle differences across the lifespan.

Authors:  Analiza M Silva; Wei Shen; Moonseong Heo; Dympna Gallagher; Zimian Wang; Luis B Sardinha; Steven B Heymsfield
Journal:  Am J Hum Biol       Date:  2010 Jan-Feb       Impact factor: 1.937

7.  Replication study of the vitamin D receptor (VDR) genotype association with skeletal muscle traits and sarcopenia.

Authors:  Sean Walsh; Andrew T Ludlow; E Jeffrey Metter; Luigi Ferrucci; Stephen M Roth
Journal:  Aging Clin Exp Res       Date:  2015-09-28       Impact factor: 3.636

8.  Prevalence and associated factors of sarcopenia among elderly in Brazil: findings from the SABE study.

Authors:  T da Silva Alexandre; Y A de Oliveira Duarte; J L Ferreira Santos; R Wong; M L Lebrão
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

9.  Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review.

Authors:  W Kyle Mitchell; John Williams; Philip Atherton; Mike Larvin; John Lund; Marco Narici
Journal:  Front Physiol       Date:  2012-07-11       Impact factor: 4.566

10.  Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis.

Authors:  Meltem Alkan Melikoğlu
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.